The 51st Annual Meeting of the European Society of Blood and Marrow Transplantation (EBMT 2025) focuses on advancements in hematopoietic stem cell transplantation, cell therapy, and gene therapy, with a strong emphasis on disease-specific treatments, quality management, and data management.
Topics
- Disease-specific topics
- Aplastic anaemia
- Acute leukaemia
- Chronic leukaemia
- Autoimmune diseases
- Lymphoma
- Haemoglobinopathy and Inborn errors of metabolism
- Myelodysplasia
- Multiple myeloma
- Solid tumours
- General Topics
- Hematopoietic stem cells
- Cell therapy
- Gene Therapy
- Regenerative medicine
- Stem cell mobilisation and Graft engineering
- Non-hematopoietic stem cells
- QUALITY MANAGEMENT GROUP
- Quality management
- Accreditation
- Sharing best practice
- Regulatory issues
- Transplant-specific topics
- Stem cell donor
- Stem cell source
- Graft-versus-host disease – clinical
- Graft-versus-host disease – preclinical and animal models
- Early complications / Late effects & quality of life
- Infectious complications
- Minimal residual disease, Tolerance, Chimerism and Immune reconstitution
- Reduced-intensity conditioning
- Experimental stem cell transplantation and Tumour stem cells
- Paediatric issues
- DATA MANAGEMENT GROUP
- Statistics
- Data Management
